• About us
• Contact

Advertisement

Product › Details

TEN-010 (Tensha/Roche)

	Next higher product group	BET bromodomain inhibitor
	Status	2016-01-11 development p1 existent

Record changed: 2023-07-10

Advertisement

More documents for cancer drug

• [1] Recipharm AB. (6/8/26). "Press Release: Recipharm and Fusix Biotech Advance Novel Oncolytic Virus Platform". Darmstadt....
• [2] Ona Therapeutics S.L.. (6/4/26). "Press Release: Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development". Barcelona....
• [3] Nanobiotix S.A.. (5/21/26). "Press Release: Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering". Paris & Cambridge, MA....
• [4] Formycon AG. (5/19/26). "Press Release: Formycon Expands Commercial Portfolio – Aflibercept Biosimilars Ahzantive and Baiama Are Now Available in the European Union". Planegg-Martinsried....
• [5] CellCentric Ltd.. (5/6/26). "Press Release: CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma". Cambridge & Boston, MA....
• [6] Kahimmune Therapeutics SAS. (4/28/26). "Press Release: Kahimmune Therapeutics Signs Agreement for Scientific Collaboration with Gustave Roussy". Avignon....
• [7] Coultreon Biopharma B.V.. (4/28/26). "Press Release: Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline". Leuven....
• [8] Servier. (4/23/26). "Press Release: Servier Completes the Acquisition of Day One Biopharmaceuticals". Suresnes....
• [9] Storm Therapeutics Ltd.. (4/16/26). "Press Release: Storm Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC-15". Cambridge....
• [10] Boehringer Ingelheim. (4/15/26). "Press Release: Boehringer Ingelheim and Zai Lab announce collaboration on DLL3-targeting T-Cell Engager and ADC combination in Small Cell Lung Cancer and other Neuroendocrine Carcinomas". Ingelheim, Shanghai & Cambridge,...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.